Shopping cart $0
Search
The 15th International Congress on Autoimmunity brings together clinicians, researchers, and healthcare professionals dedicated to the study and treatment of autoimmune diseases. Its expert programme includes plenary sessions, parallel tracks, debates, teaching courses, and oral presentations of selected abstracts, creating a broad platform for knowledge sharing and professional exchange. Combined with the accompanying exhibition, the congress offers space not only for scientific discussion, but also for presenting new diagnostic approaches and technologies. Bringing together more than 1,500 experts from over 70 countries, it represents an important international meeting point for the autoimmune community.
Date: 14–17 May 2026
Venue: Prague Congress Centre, Praha Czech Republic
Booth: 26
Web: https://autoimmunity.kenes.com/
Contact: Barbora Vrana, vrana@biovendor.cz
BioVendor Group will take part in the congress at booth no. 26, where we will present selected solutions from our autoimmune diagnostics portfolio and offer visitors an opportunity to explore the CLIA and MBA technologies showcased at the booth.
With a portfolio covering systemic and rheumatic autoimmune diseases, autoimmune liver and gastrointestinal disorders, and antiphospholipid-related markers, BioVendor has a strong offering for laboratories looking for reliable and flexible solutions in autoimmune diagnostics. These areas are supported by multiple proven technologies, including ELISA, immunoblot, CLIA, and the multiplex Microblot-Array (MBA) platform. We look forward to meeting you in Prague.
The EACR 2026 Congress is a four-day international meeting dedicated to basic, preclinical, and translational cancer research. It brings together the cancer research community to share the latest findings, inspire innovation, and build knowledge, connections, and collaborations across a wide range of oncology topics. Together with the accompanying exhibition, the congress provides a platform for scientific exchange and the presentation of advanced diagnostic technologies.
Date: June 8–11, 2026
Venue: Budapest, Hungary
Booth: 61
Website: https://www.eacr.org/congress/
Contact: Iveta Tóthová, tothova@biovendor-mdx.com
BioVendor will take part in the congress at booth no. 61, where we will present our molecular diagnostics portfolio designed to support modern laboratory workflows.
BioVendor advances molecular diagnostics from PCR to high-precision NGS, connecting wet lab workflows with data insight powered by GENOVESA bioinformatics software. Our portfolio includes RealFast® for qPCR, StripAssay® for reverse hybridization, and fastGEN® and epicGEN® for NGS. These solutions support oncology, pharmacogenetics, genetic disorders, predisposition testing, and microbiome research for clinical and research laboratories.
Visitors are welcome to meet our team, explore how our technologies can be implemented into routine diagnostic workflows, and schedule a meeting with us.
We look forward to meeting you in Budapest.
BioVendor brings a unique diagnostic advantage with a fully automated CLIA panel combining functional markers C-peptide and Insulin with autoimmune markers GAD65 and IA-2, supporting faster and more accurate diabetes differentiation.
Read more
BioVendor is introducing SophoMer™ F10: a synthetic polymer that improves the accuracy and reliability of diagnostic tests, replacing BSA in laboratories.
Read more
A gathering that annually brings together leaders in laboratory diagnostics, innovators, and business partners from around the world. BioVendor was once again part of it.
Read more
The Chairman of BioVendor brings decades of experience, humility and a passion for building things together.
Read more
NeuroConnect Meetup in Brno brought together scientists, clinicians and innovators and opened up new opportunities for collaboration in research on neurodegenerative diseases.
Read more
The trade fair offered an ideal opportunity to present BioVendor Group in its new, unified form and reaffirm its role in laboratory diagnostics innovation.
Read more
Chronic kidney disease is often detected too late. Uromodulin offers a new perspective for earlier and more sensitive diagnostics.
Read more
Chronic kidney disease is often detected too late. Uromodulin offers a new perspective for earlier and more sensitive diagnostics.
Read more
At our booth #4255, we showcased the Group’s portfolio, created through the synergy of research, development, and technological expertise across BioVendor Group.
Read more
Brussels hosted the 26th edition of the prestigious international congress focused on clinical chemistry and laboratory medicine. We were there – both as an exhibitor and as a contributor to the scientific programme.
Read more
Focusing on the latest trends and technologies in laboratory diagnostic
Read more
Get to know epicGEN – next-generation NGS panels for precise genome analysis. The new epicGEN Solid Cancer & MSI Kit is designed for targeted analysis of 42 genes relevant for the diagnostics of solid tumors and the detection of genetic changes (InDel, SNP, CNV and MSI).
Read more
BioVendor Group changes ownership to partner with a healthcare specialist, strengthening its development and expansion capacities in the global diagnostics market.
Read more
From sequencing to artificial intelligence: Trends shaping the future of laboratory diagnostics
Read more
We’re excited to introduce our new GENOVESA website, designed to provide you with seamless access to advanced software solutions.
Read more
While this motto sets the tone for the upcoming MEDICA 2025, it perfectly encapsulated the spirit of this year’s event, which took place in the second week of November in Düsseldorf.
Read more
BioVendor Group introduces the innovative test for the detection of microsatellite instability leverages state-of-the-art NGS technology
Read more
Reveal lactose, fructose, and histamine intolerance with NGS – all in one test.
Read more
Cutting-edge immunological biomarker and its role in managing infections and immune responses
Read more
The 57th ESHG 2024 is behind us, gathering over 4,500 experts in human genetics.
Read more
BioVendor MDx introduces the first commercial NGS assay for the detection of the BCR::ABL1 fusion gene.
Read more
The BioVendor Group CLIA project is in its third year of operation on the market and is successfully establishing itself in prestigious workplaces in the Czech Republic and other markets.
Read more
First impressions of Medlab 2024
Read more
Together under one roof of BioVendor Group again after one year in Düsseldorf.
Read more
The ECCMID conference showcased the latest findings in clinical microbiology and infectious diseases. And BioVendor Group was part of it!
Read more
A major advance in personalized medicine.
Read more
These were the words of Michal Šteffl, Head of International Sales at TestLine, who summed up the participation of BioVendor Group companies at the most important event in the MENA region.
Read more
It is an annual occasion to meet our current business partners and suppliers and make new connections.
Read more
We introduced a new tool for effective endometrial tumor analysis at the Mendel genetics conference.
Read more
BioVendor Group establishes the molecular diagnostic division BioVendor MDx.
Read more
The most important medical fair took place in its usual autumn term from 15 to 18 November 2021 in Düsseldorf, Germany.
Read more
BioVendor developed user friendly diagnostic NGS kits with excellent analytical parameters and extremely fast processing for laboratories of any size.
Read more
BioVendor Group becomes the exclusive distributor of innovative tests to detect testicular cancer.
Read more
Introducing the CLIA solution from BioVendor Group – an attractive portfolio of parameters, finely-tuned automation, new diagnostic possibilities.
Read more
The prestigious Medlab Middle East 2021 show took place in Dubai from 21st to 24th June, and we couldn't miss it.
Read more
Fully automated CLIA solution with diagnostic parameters from BioVendor Group
Read more
Introducing the new BioVendor Group identity!
Read more
TEAMS internet platform
BioVendor is a proud member of strong academic-industrial consortium focused on research and development in the field of non-coding RNA diagnostics in oncology!
Read more
BioVendor is a proud member of a unique research cluster for the treatment of stroke
Read more
We have established a new product segment within the BioVendor portfolio covering covid-19 relevant products.
Read more
We continue to manufacture and supply in an unchanged manner!
Read more
BioVendor was a part of the largest attended laboratory expo worldwide.
Read more
Now we are getting closer to our goal - translating miRNA biomarkers from research to clinical diagnostics!
Read more
A succesful exhibition at MEDICA attracted many visitors and business partners.
Read more
BioVendor researchers evaluate “Clinical Utility of Current microRNA Detection Methods” in a BioTechniques journal article.
Read more
We are pleased to announce that we have successfully participated in the External Quality Assessment (Referenzinstitut für Bioanalytik, survey of March 2019), being involved in determination of IL-6.
Read more
We are so proud that BioVendor's ANGPTL3 Human ELISA participated in a major study.
Read more
Great pleasure! We thank all who attended BioVendor seminar where MiRXES introduced GASTROClear, a diagnostic microRNA panel for Gastric cancer screening.
Read more
We are pleased to announce that we have successfully participated in the External Quality Assessment (INSTAND, survey of March 20, 2019), being involved in determination of Cystatin C.
Read more
We would like to invite you to a one-day expert seminar organized in cooperation with MiRXES on May 13, 2019.
Read more
BioVendor held distributor meeting in Brno with tour the laboratories and visiting unique Mendel Museum & Augustinian Abbey in Brno.
Read more
Great to see everyone at 9th Gene Quantification Event in Freising-Weihenstephan.
Read more
BioVendor was a part of the largest attended laboratory expo worldwide.
Read more
3rd Annual distributor meeting of BioVendor Group was in a new format this year.
Read more
A succesful exhibition at MEDICA attracted many visitors and business partners.
Read more
BioVendor was a part of the AACC congress in Chicago, USA.
Read more
We will introduce BioVendor original miREIA method for microRNA quantification at the Harvard Medical School soon.
Read more
Within the framework of our continous expansion of IVD products, we are happy to announce that further BioVendor products are now available for IVD use.
Read more
BioVendor was a part of the European Atherosclerosis Society (EAS) congress in Lisbon, Portugal.
Read more
BioVendor was a part of the largest attended laboratory expo worldwide
Read more
A succesful exhibition at MEDICA attracted many visitors and business partners
Read more
We are proud to announce launch of the first miREIA kit.
Read more
miREIA Presented at the AACC 2017, San Diego
Read more